Global Human Vaccines Administered Orally Market Growth 2022-2028

Publisher Name :
Date: 17-Jan-2022
No. of pages: 116

As the global economy mends, the 2021 growth of Human Vaccines Administered Orally will have significant change from previous year. According to our (LP Information) latest study, the global Human Vaccines Administered Orally market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Human Vaccines Administered Orally market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Human Vaccines Administered Orally market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Human Vaccines Administered Orally market, reaching US$ million by the year 2028. As for the Europe Human Vaccines Administered Orally landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Human Vaccines Administered Orally players cover Merck, GSK, Sanofi, and Lanzhou Institute, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Vaccines Administered Orally market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

- Rotavirus Vaccine

- Cholera Vaccine

- Oral Polio Vaccine

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

- Public

- Private

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

- Merck

- GSK

- Sanofi

- Lanzhou Institute

- Serum Institute

- Valneva

- Shanghai United Cell

- Bibcol

- PaxVax

- Vabiotech

- Tiantan Biological

- EuBiologics

- Panacea Biotec Ltd

- Bio-Med

- Halfkin Bio-Pharmaceuticals

Global Human Vaccines Administered Orally Market Growth 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Vaccines Administered Orally Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Human Vaccines Administered Orally by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Human Vaccines Administered Orally by Country/Region, 2017, 2022 & 2028
2.2 Human Vaccines Administered Orally Segment by Type
2.2.1 Rotavirus Vaccine
2.2.2 Cholera Vaccine
2.2.3 Oral Polio Vaccine
2.3 Human Vaccines Administered Orally Sales by Type
2.3.1 Global Human Vaccines Administered Orally Sales Market Share by Type (2017-2022)
2.3.2 Global Human Vaccines Administered Orally Revenue and Market Share by Type (2017-2022)
2.3.3 Global Human Vaccines Administered Orally Sale Price by Type (2017-2022)
2.4 Human Vaccines Administered Orally Segment by Application
2.4.1 Public
2.4.2 Private
2.5 Human Vaccines Administered Orally Sales by Application
2.5.1 Global Human Vaccines Administered Orally Sale Market Share by Application (2017-2022)
2.5.2 Global Human Vaccines Administered Orally Revenue and Market Share by Application (2017-2022)
2.5.3 Global Human Vaccines Administered Orally Sale Price by Application (2017-2022)
3 Global Human Vaccines Administered Orally by Company
3.1 Global Human Vaccines Administered Orally Breakdown Data by Company
3.1.1 Global Human Vaccines Administered Orally Annual Sales by Company (2020-2022)
3.1.2 Global Human Vaccines Administered Orally Sales Market Share by Company (2020-2022)
3.2 Global Human Vaccines Administered Orally Annual Revenue by Company (2020-2022)
3.2.1 Global Human Vaccines Administered Orally Revenue by Company (2020-2022)
3.2.2 Global Human Vaccines Administered Orally Revenue Market Share by Company (2020-2022)
3.3 Global Human Vaccines Administered Orally Sale Price by Company
3.4 Key Manufacturers Human Vaccines Administered Orally Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Vaccines Administered Orally Product Location Distribution
3.4.2 Players Human Vaccines Administered Orally Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Human Vaccines Administered Orally by Geographic Region
4.1 World Historic Human Vaccines Administered Orally Market Size by Geographic Region (2017-2022)
4.1.1 Global Human Vaccines Administered Orally Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Human Vaccines Administered Orally Annual Revenue by Geographic Region
4.2 World Historic Human Vaccines Administered Orally Market Size by Country/Region (2017-2022)
4.2.1 Global Human Vaccines Administered Orally Annual Sales by Country/Region (2017-2022)
4.2.2 Global Human Vaccines Administered Orally Annual Revenue by Country/Region
4.3 Americas Human Vaccines Administered Orally Sales Growth
4.4 APAC Human Vaccines Administered Orally Sales Growth
4.5 Europe Human Vaccines Administered Orally Sales Growth
4.6 Middle East & Africa Human Vaccines Administered Orally Sales Growth
5 Americas
5.1 Americas Human Vaccines Administered Orally Sales by Country
5.1.1 Americas Human Vaccines Administered Orally Sales by Country (2017-2022)
5.1.2 Americas Human Vaccines Administered Orally Revenue by Country (2017-2022)
5.2 Americas Human Vaccines Administered Orally Sales by Type
5.3 Americas Human Vaccines Administered Orally Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Vaccines Administered Orally Sales by Region
6.1.1 APAC Human Vaccines Administered Orally Sales by Region (2017-2022)
6.1.2 APAC Human Vaccines Administered Orally Revenue by Region (2017-2022)
6.2 APAC Human Vaccines Administered Orally Sales by Type
6.3 APAC Human Vaccines Administered Orally Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Human Vaccines Administered Orally by Country
7.1.1 Europe Human Vaccines Administered Orally Sales by Country (2017-2022)
7.1.2 Europe Human Vaccines Administered Orally Revenue by Country (2017-2022)
7.2 Europe Human Vaccines Administered Orally Sales by Type
7.3 Europe Human Vaccines Administered Orally Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Vaccines Administered Orally by Country
8.1.1 Middle East & Africa Human Vaccines Administered Orally Sales by Country (2017-2022)
8.1.2 Middle East & Africa Human Vaccines Administered Orally Revenue by Country (2017-2022)
8.2 Middle East & Africa Human Vaccines Administered Orally Sales by Type
8.3 Middle East & Africa Human Vaccines Administered Orally Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Vaccines Administered Orally
10.3 Manufacturing Process Analysis of Human Vaccines Administered Orally
10.4 Industry Chain Structure of Human Vaccines Administered Orally
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Vaccines Administered Orally Distributors
11.3 Human Vaccines Administered Orally Customer
12 World Forecast Review for Human Vaccines Administered Orally by Geographic Region
12.1 Global Human Vaccines Administered Orally Market Size Forecast by Region
12.1.1 Global Human Vaccines Administered Orally Forecast by Region (2023-2028)
12.1.2 Global Human Vaccines Administered Orally Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Vaccines Administered Orally Forecast by Type
12.7 Global Human Vaccines Administered Orally Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Human Vaccines Administered Orally Product Offered
13.1.3 Merck Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Human Vaccines Administered Orally Product Offered
13.2.3 GSK Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Human Vaccines Administered Orally Product Offered
13.3.3 Sanofi Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Lanzhou Institute
13.4.1 Lanzhou Institute Company Information
13.4.2 Lanzhou Institute Human Vaccines Administered Orally Product Offered
13.4.3 Lanzhou Institute Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Lanzhou Institute Main Business Overview
13.4.5 Lanzhou Institute Latest Developments
13.5 Serum Institute
13.5.1 Serum Institute Company Information
13.5.2 Serum Institute Human Vaccines Administered Orally Product Offered
13.5.3 Serum Institute Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Serum Institute Main Business Overview
13.5.5 Serum Institute Latest Developments
13.6 Valneva
13.6.1 Valneva Company Information
13.6.2 Valneva Human Vaccines Administered Orally Product Offered
13.6.3 Valneva Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Valneva Main Business Overview
13.6.5 Valneva Latest Developments
13.7 Shanghai United Cell
13.7.1 Shanghai United Cell Company Information
13.7.2 Shanghai United Cell Human Vaccines Administered Orally Product Offered
13.7.3 Shanghai United Cell Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Shanghai United Cell Main Business Overview
13.7.5 Shanghai United Cell Latest Developments
13.8 Bibcol
13.8.1 Bibcol Company Information
13.8.2 Bibcol Human Vaccines Administered Orally Product Offered
13.8.3 Bibcol Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bibcol Main Business Overview
13.8.5 Bibcol Latest Developments
13.9 PaxVax
13.9.1 PaxVax Company Information
13.9.2 PaxVax Human Vaccines Administered Orally Product Offered
13.9.3 PaxVax Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 PaxVax Main Business Overview
13.9.5 PaxVax Latest Developments
13.10 Vabiotech
13.10.1 Vabiotech Company Information
13.10.2 Vabiotech Human Vaccines Administered Orally Product Offered
13.10.3 Vabiotech Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Vabiotech Main Business Overview
13.10.5 Vabiotech Latest Developments
13.11 Tiantan Biological
13.11.1 Tiantan Biological Company Information
13.11.2 Tiantan Biological Human Vaccines Administered Orally Product Offered
13.11.3 Tiantan Biological Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Tiantan Biological Main Business Overview
13.11.5 Tiantan Biological Latest Developments
13.12 EuBiologics
13.12.1 EuBiologics Company Information
13.12.2 EuBiologics Human Vaccines Administered Orally Product Offered
13.12.3 EuBiologics Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 EuBiologics Main Business Overview
13.12.5 EuBiologics Latest Developments
13.13 Panacea Biotec Ltd
13.13.1 Panacea Biotec Ltd Company Information
13.13.2 Panacea Biotec Ltd Human Vaccines Administered Orally Product Offered
13.13.3 Panacea Biotec Ltd Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Panacea Biotec Ltd Main Business Overview
13.13.5 Panacea Biotec Ltd Latest Developments
13.14 Bio-Med
13.14.1 Bio-Med Company Information
13.14.2 Bio-Med Human Vaccines Administered Orally Product Offered
13.14.3 Bio-Med Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Bio-Med Main Business Overview
13.14.5 Bio-Med Latest Developments
13.15 Halfkin Bio-Pharmaceuticals
13.15.1 Halfkin Bio-Pharmaceuticals Company Information
13.15.2 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product Offered
13.15.3 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Halfkin Bio-Pharmaceuticals Main Business Overview
13.15.5 Halfkin Bio-Pharmaceuticals Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Human Vaccines Administered Orally Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Human Vaccines Administered Orally Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Rotavirus Vaccine
Table 4. Major Players of Cholera Vaccine
Table 5. Major Players of Oral Polio Vaccine
Table 6. Global Human Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
Table 7. Global Human Vaccines Administered Orally Sales Market Share by Type (2017-2022)
Table 8. Global Human Vaccines Administered Orally Revenue by Type (2017-2022) & ($ million)
Table 9. Global Human Vaccines Administered Orally Revenue Market Share by Type (2017-2022)
Table 10. Global Human Vaccines Administered Orally Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Human Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)
Table 12. Global Human Vaccines Administered Orally Sales Market Share by Application (2017-2022)
Table 13. Global Human Vaccines Administered Orally Revenue by Application (2017-2022)
Table 14. Global Human Vaccines Administered Orally Revenue Market Share by Application (2017-2022)
Table 15. Global Human Vaccines Administered Orally Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Human Vaccines Administered Orally Sales by Company (2020-2022) & (K Units)
Table 17. Global Human Vaccines Administered Orally Sales Market Share by Company (2020-2022)
Table 18. Global Human Vaccines Administered Orally Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Human Vaccines Administered Orally Revenue Market Share by Company (2020-2022)
Table 20. Global Human Vaccines Administered Orally Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Human Vaccines Administered Orally Producing Area Distribution and Sales Area
Table 22. Players Human Vaccines Administered Orally Products Offered
Table 23. Human Vaccines Administered Orally Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Human Vaccines Administered Orally Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Human Vaccines Administered Orally Sales Market Share Geographic Region (2017-2022)
Table 28. Global Human Vaccines Administered Orally Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Human Vaccines Administered Orally Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Human Vaccines Administered Orally Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Human Vaccines Administered Orally Sales Market Share by Country/Region (2017-2022)
Table 32. Global Human Vaccines Administered Orally Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Human Vaccines Administered Orally Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Human Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)
Table 35. Americas Human Vaccines Administered Orally Sales Market Share by Country (2017-2022)
Table 36. Americas Human Vaccines Administered Orally Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Human Vaccines Administered Orally Revenue Market Share by Country (2017-2022)
Table 38. Americas Human Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
Table 39. Americas Human Vaccines Administered Orally Sales Market Share by Type (2017-2022)
Table 40. Americas Human Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)
Table 41. Americas Human Vaccines Administered Orally Sales Market Share by Application (2017-2022)
Table 42. APAC Human Vaccines Administered Orally Sales by Region (2017-2022) & (K Units)
Table 43. APAC Human Vaccines Administered Orally Sales Market Share by Region (2017-2022)
Table 44. APAC Human Vaccines Administered Orally Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Human Vaccines Administered Orally Revenue Market Share by Region (2017-2022)
Table 46. APAC Human Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
Table 47. APAC Human Vaccines Administered Orally Sales Market Share by Type (2017-2022)
Table 48. APAC Human Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)
Table 49. APAC Human Vaccines Administered Orally Sales Market Share by Application (2017-2022)
Table 50. Europe Human Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)
Table 51. Europe Human Vaccines Administered Orally Sales Market Share by Country (2017-2022)
Table 52. Europe Human Vaccines Administered Orally Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Human Vaccines Administered Orally Revenue Market Share by Country (2017-2022)
Table 54. Europe Human Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
Table 55. Europe Human Vaccines Administered Orally Sales Market Share by Type (2017-2022)
Table 56. Europe Human Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)
Table 57. Europe Human Vaccines Administered Orally Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Human Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Human Vaccines Administered Orally Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Human Vaccines Administered Orally Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Human Vaccines Administered Orally Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Human Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Human Vaccines Administered Orally Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Human Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Human Vaccines Administered Orally Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Human Vaccines Administered Orally
Table 67. Key Market Challenges & Risks of Human Vaccines Administered Orally
Table 68. Key Industry Trends of Human Vaccines Administered Orally
Table 69. Human Vaccines Administered Orally Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Human Vaccines Administered Orally Distributors List
Table 72. Human Vaccines Administered Orally Customer List
Table 73. Global Human Vaccines Administered Orally Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Human Vaccines Administered Orally Sales Market Forecast by Region
Table 75. Global Human Vaccines Administered Orally Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Human Vaccines Administered Orally Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Human Vaccines Administered Orally Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Human Vaccines Administered Orally Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Human Vaccines Administered Orally Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Human Vaccines Administered Orally Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Human Vaccines Administered Orally Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Human Vaccines Administered Orally Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Human Vaccines Administered Orally Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Human Vaccines Administered Orally Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Human Vaccines Administered Orally Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Human Vaccines Administered Orally Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Human Vaccines Administered Orally Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Human Vaccines Administered Orally Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Human Vaccines Administered Orally Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Human Vaccines Administered Orally Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Human Vaccines Administered Orally Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Human Vaccines Administered Orally Revenue Market Share Forecast by Application (2023-2028)
Table 93. Merck Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 94. Merck Human Vaccines Administered Orally Product Offered
Table 95. Merck Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Merck Main Business
Table 97. Merck Latest Developments
Table 98. GSK Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 99. GSK Human Vaccines Administered Orally Product Offered
Table 100. GSK Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. GSK Main Business
Table 102. GSK Latest Developments
Table 103. Sanofi Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 104. Sanofi Human Vaccines Administered Orally Product Offered
Table 105. Sanofi Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Sanofi Main Business
Table 107. Sanofi Latest Developments
Table 108. Lanzhou Institute Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 109. Lanzhou Institute Human Vaccines Administered Orally Product Offered
Table 110. Lanzhou Institute Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Lanzhou Institute Main Business
Table 112. Lanzhou Institute Latest Developments
Table 113. Serum Institute Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 114. Serum Institute Human Vaccines Administered Orally Product Offered
Table 115. Serum Institute Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Serum Institute Main Business
Table 117. Serum Institute Latest Developments
Table 118. Valneva Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 119. Valneva Human Vaccines Administered Orally Product Offered
Table 120. Valneva Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Valneva Main Business
Table 122. Valneva Latest Developments
Table 123. Shanghai United Cell Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 124. Shanghai United Cell Human Vaccines Administered Orally Product Offered
Table 125. Shanghai United Cell Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Shanghai United Cell Main Business
Table 127. Shanghai United Cell Latest Developments
Table 128. Bibcol Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 129. Bibcol Human Vaccines Administered Orally Product Offered
Table 130. Bibcol Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Bibcol Main Business
Table 132. Bibcol Latest Developments
Table 133. PaxVax Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 134. PaxVax Human Vaccines Administered Orally Product Offered
Table 135. PaxVax Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. PaxVax Main Business
Table 137. PaxVax Latest Developments
Table 138. Vabiotech Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 139. Vabiotech Human Vaccines Administered Orally Product Offered
Table 140. Vabiotech Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Vabiotech Main Business
Table 142. Vabiotech Latest Developments
Table 143. Tiantan Biological Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 144. Tiantan Biological Human Vaccines Administered Orally Product Offered
Table 145. Tiantan Biological Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Tiantan Biological Main Business
Table 147. Tiantan Biological Latest Developments
Table 148. EuBiologics Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 149. EuBiologics Human Vaccines Administered Orally Product Offered
Table 150. EuBiologics Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. EuBiologics Main Business
Table 152. EuBiologics Latest Developments
Table 153. Panacea Biotec Ltd Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 154. Panacea Biotec Ltd Human Vaccines Administered Orally Product Offered
Table 155. Panacea Biotec Ltd Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. Panacea Biotec Ltd Main Business
Table 157. Panacea Biotec Ltd Latest Developments
Table 158. Bio-Med Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 159. Bio-Med Human Vaccines Administered Orally Product Offered
Table 160. Bio-Med Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 161. Bio-Med Main Business
Table 162. Bio-Med Latest Developments
Table 163. Halfkin Bio-Pharmaceuticals Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 164. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product Offered
Table 165. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 166. Halfkin Bio-Pharmaceuticals Main Business
Table 167. Halfkin Bio-Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Human Vaccines Administered Orally
Figure 2. Human Vaccines Administered Orally Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Vaccines Administered Orally Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Human Vaccines Administered Orally Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Human Vaccines Administered Orally Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Rotavirus Vaccine
Figure 10. Product Picture of Cholera Vaccine
Figure 11. Product Picture of Oral Polio Vaccine
Figure 12. Global Human Vaccines Administered Orally Sales Market Share by Type in 2021
Figure 13. Global Human Vaccines Administered Orally Revenue Market Share by Type (2017-2022)
Figure 14. Human Vaccines Administered Orally Consumed in Public
Figure 15. Global Human Vaccines Administered Orally Market: Public (2017-2022) & (K Units)
Figure 16. Human Vaccines Administered Orally Consumed in Private
Figure 17. Global Human Vaccines Administered Orally Market: Private (2017-2022) & (K Units)
Figure 18. Global Human Vaccines Administered Orally Sales Market Share by Application (2017-2022)
Figure 19. Global Human Vaccines Administered Orally Revenue Market Share by Application in 2021
Figure 20. Human Vaccines Administered Orally Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Human Vaccines Administered Orally Revenue Market Share by Company in 2021
Figure 22. Global Human Vaccines Administered Orally Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Human Vaccines Administered Orally Revenue Market Share by Geographic Region in 2021
Figure 24. Global Human Vaccines Administered Orally Sales Market Share by Region (2017-2022)
Figure 25. Global Human Vaccines Administered Orally Revenue Market Share by Country/Region in 2021
Figure 26. Americas Human Vaccines Administered Orally Sales 2017-2022 (K Units)
Figure 27. Americas Human Vaccines Administered Orally Revenue 2017-2022 ($ Millions)
Figure 28. APAC Human Vaccines Administered Orally Sales 2017-2022 (K Units)
Figure 29. APAC Human Vaccines Administered Orally Revenue 2017-2022 ($ Millions)
Figure 30. Europe Human Vaccines Administered Orally Sales 2017-2022 (K Units)
Figure 31. Europe Human Vaccines Administered Orally Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Human Vaccines Administered Orally Sales 2017-2022 (K Units)
Figure 33. Middle East & Africa Human Vaccines Administered Orally Revenue 2017-2022 ($ Millions)
Figure 34. Americas Human Vaccines Administered Orally Sales Market Share by Country in 2021
Figure 35. Americas Human Vaccines Administered Orally Revenue Market Share by Country in 2021
Figure 36. United States Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Human Vaccines Administered Orally Sales Market Share by Region in 2021
Figure 41. APAC Human Vaccines Administered Orally Revenue Market Share by Regions in 2021
Figure 42. China Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Human Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Human Vaccines A
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs